Faculty profile

Heather Galipeau

Back to faculty

Assistant Professor (Part-Time)MedicineMcMaster University

Heather Galipeau

Assistant Professor (Part-Time)

Medicine

Faculty of Health Sciences

McMaster University

Hamilton, Ontario, Canada

In this role since 2023

Email ORCID

Supervision signals

Adjunct, part-time and visiting faculty usually co-supervise alongside a core faculty member.
No graduate courses on record.
57 publications in the last five years, latest in 2026.
Senior (last) author on 3 recent papers, a sign of leading a research group.

These signals come from public records. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

122

Publications

3,360

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Academic profiles

University Profile Search on Google Scholar iDORCID OpenAlex

Social profiles

𝕏Search on X inSearch on LinkedIn 🦋Search on Bluesky ▶Search on YouTube

Contact

galipehj@mcmaster.ca

Research

Research areas, by share of publications

Celiac Disease Research and ManagementMedicine
Gut microbiota and healthBiochemistry, Genetics and Molecular Biology
Inflammatory Bowel DiseaseBiochemistry, Genetics and Molecular Biology

Research areas are derived from OpenAlex topics of their publications.

122 publications.

Small intestinal microbial fiber metabolism dysfunction in celiac disease

Wulczynski M, Constante M, Galipeau HJ, Blom J, Rueda GH, El-Chaar N, Superdock DK, Jiang S, David LA, Murray JA

Nature Communications20266 citations

DOI: 10.1038/s41467-026-70644-4

Phage intervention improves colitis and response to corticosteroids by attenuating virulence of Crohn’s disease–associated bacteria

Jackson K, Galipeau HJ, Hann A, Constante M, Zangara MT, Bording-Jorgensen M, Fuentes A, Ho H, Wang J, Shimbori C

Science Translational Medicine20263 citations

DOI: 10.1126/scitranslmed.adz4589

Saccharomyces boulardii CNCM I-745 synergizes with the small intestinal microbiota to boost AhR signaling in celiac disease

Kan KR, Constante M, Rahmani S, Rueda GH, Wulczynski M, Pinto-Sanchez MI, Roux X, Bercik P, Galipeau HJ, Caminero A

Gut Microbes20261 citations

DOI: 10.1080/19490976.2026.2664640

SUPPRESSION OF CROHN'S-ASSOCIATED BACTERIAL VIRULENCE BY PRECISION PHAGE THERAPY MITIGATES COLITIS AND ENHANCES STEROID EFFICACY

Jackson K, Galipeau HJ, Hann A, Zangara M, Jorgensen MB, Coombes B, Hosseinidoust Z, Verdu EF

Gastroenterology2026

A13 PRECISION PHAGE THERAPY MITIGATES COLITIS AND ENHANCES STEROID EFFICACY THROUGH SUPPRESSION OF CROHN’S-ASSOCIATED BACTERIAL VIRULENCE

Jackson K, Galipeau H, Hann A, Zangara M, Bording-Jorgensen M, Coombes B, Hosseinidoust Z, Verdu EF

Journal of the Canadian Association of Gastroenterology2026

DOI: 10.1093/jcag/gwaf042.013

Poster Session II - A252 THE EFFECT OF LACTICASEIBACILLUS RHAMNOSUS STRAIN C51 IN THE PREVENTION OF COLITIS IN HIGH PROTEOLYTIC IBD MICROBIOTA COLONIZED MICE

Bowerman B, Hann A, Orea XM, Bording-Jorgensen M, Gontier S, Aucouturier A, Naas I, Bercik P, Surette M, Galipeau H

Journal of the Canadian Association of Gastroenterology2026Senior author

DOI: 10.1093/jcag/gwaf042.251

A14 SACCHAROMYCES BOULARDII CNCM I-745 SYNERGIZES WITH THE SMALL INTESTINAL MICROBIOTA TO BOOST AHR SIGNALING IN CELIAC DISEASE

Kan K, Constante M, Rahmani S, Rueda G, Pinto-Sanchez M, Roux X, Bercik P, Galipeau H, Caminero A, Verdu EF

Journal of the Canadian Association of Gastroenterology2026

DOI: 10.1093/jcag/gwaf042.014

825 SUPPRESSION OF CROHN’S-ASSOCIATED BACTERIAL VIRULENCE BY PRECISION PHAGE THERAPY MITIGATES COLITIS AND ENHANCES STEROID EFFICACY

Jackson K, Galipeau HJ, Hann A, Zangara M, Bording-Jorgensen M, Coombes B, Hosseinidoust Z, Verdu EF

Gastroenterology2026

DOI: 10.1016/s0016-5085(26)02382-6

825 SUPPRESSION OF CROHN’S-ASSOCIATED BACTERIAL VIRULENCE BY PRECISION PHAGE THERAPY MITIGATES COLITIS AND ENHANCES STEROID EFFICACY

Jackson K, Galipeau HJ, Hann A, Zangara M, Bording-Jorgensen M, Coombes B, Hosseinidoust Z, Verdu EF

Gastrointestinal Endoscopy2026

DOI: 10.1016/s0016-5107(26)02313-8

A8 MATERNAL IBD-ASSOCIATED MICROBIOTA SHAPES IMMUNE SYSTEM IN OFFSPRING

Orea XM, Hann A, Bowerman B, Bellissimo C, Pazoki B, Kennedy K, Constante M, Sloboda D, Galipeau H, Verdu EF

Journal of the Canadian Association of Gastroenterology2026

DOI: 10.1093/jcag/gwaf042.008

Research institutes and memberships

Farncombe Family Digestive Health Research Institute

Researchers with similar interests

Alberto Caminero Fernandez

Medicine

Celiac Disease Research and Management, Gut microbiota and health

Elena Verdu

Medicine

Celiac Disease Research and Management, Gut microbiota and health

Herbert Brill

Pediatrics

Celiac Disease Research and Management, Inflammatory Bowel Disease

Jenna Dowhaniuk

Pediatrics

Celiac Disease Research and Management, Inflammatory Bowel Disease

Nikhil Pai

Pediatrics

Gut microbiota and health, Inflammatory Bowel Disease

Maria Pinto-Sanchez

Medicine

Celiac Disease Research and Management, Inflammatory Bowel Disease

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student: Celiac Disease Research and Management Dear Professor Galipeau, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Small intestinal microbial fiber metabolism dysfunction in celiac disease" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Open in email

Something wrong or missing on this profile? Suggest a correction

Heather Galipeau

Research

Small intestinal microbial fiber metabolism dysfunction in celiac disease

Phage intervention improves colitis and response to corticosteroids by attenuating virulence of Crohn’s disease–associated bacteria

Saccharomyces boulardii CNCM I-745 synergizes with the small intestinal microbiota to boost AhR signaling in celiac disease

SUPPRESSION OF CROHN'S-ASSOCIATED BACTERIAL VIRULENCE BY PRECISION PHAGE THERAPY MITIGATES COLITIS AND ENHANCES STEROID EFFICACY

A13 PRECISION PHAGE THERAPY MITIGATES COLITIS AND ENHANCES STEROID EFFICACY THROUGH SUPPRESSION OF CROHN’S-ASSOCIATED BACTERIAL VIRULENCE

Poster Session II - A252 THE EFFECT OF LACTICASEIBACILLUS RHAMNOSUS STRAIN C51 IN THE PREVENTION OF COLITIS IN HIGH PROTEOLYTIC IBD MICROBIOTA COLONIZED MICE

A14 SACCHAROMYCES BOULARDII CNCM I-745 SYNERGIZES WITH THE SMALL INTESTINAL MICROBIOTA TO BOOST AHR SIGNALING IN CELIAC DISEASE

825 SUPPRESSION OF CROHN’S-ASSOCIATED BACTERIAL VIRULENCE BY PRECISION PHAGE THERAPY MITIGATES COLITIS AND ENHANCES STEROID EFFICACY

825 SUPPRESSION OF CROHN’S-ASSOCIATED BACTERIAL VIRULENCE BY PRECISION PHAGE THERAPY MITIGATES COLITIS AND ENHANCES STEROID EFFICACY

A8 MATERNAL IBD-ASSOCIATED MICROBIOTA SHAPES IMMUNE SYSTEM IN OFFSPRING

Research institutes and memberships

Frequent collaborators

Elena Verdu

Premysl Bercik

Michael Surette

Alberto Caminero Fernandez

Brian Coombes

Maria Pinto-Sanchez

Researchers with similar interests

Alberto Caminero Fernandez

Elena Verdu

Herbert Brill

Jenna Dowhaniuk

Nikhil Pai

Maria Pinto-Sanchez